Ermenegildo Zegna NV
ZGN
德康医疗
DXCM
New Fortress Energy
NFE
Workday
WDAY
eBay
EBAY
(Q3)2024/09/30 | (Q2)2024/06/30 | (Q1)2024/03/31 | (FY)2023/12/31 | (Q4)2023/12/31 | (Q3)2023/09/30 | (Q2)2023/06/30 | (Q1)2023/03/31 | (FY)2022/12/31 | (Q4)2022/12/31 | |
---|---|---|---|---|---|---|---|---|---|---|
营业总收入 | 2.04%2.87亿 | 8.85%3.04亿 | 7.62%2.78亿 | 38.34%10.89亿 | 25.95%2.7亿 | 36.77%2.81亿 | 43.27%2.79亿 | 50.04%2.58亿 | 57.19%7.87亿 | 68.03%2.14亿 |
营业收入 | 2.04%2.87亿 | 8.85%3.04亿 | 7.62%2.78亿 | 38.34%10.89亿 | 25.95%2.7亿 | 36.77%2.81亿 | 43.27%2.79亿 | 50.04%2.58亿 | 57.19%7.87亿 | 68.03%2.14亿 |
主营业务成本 | 4.18%2.27亿 | 7.81%2.36亿 | 7.97%2.16亿 | 37.16%8.5亿 | 25.45%2.13亿 | 36.95%2.18亿 | 44.74%2.19亿 | 43.43%2亿 | 59.49%6.2亿 | 65.79%1.7亿 |
毛利 | -5.40%5,924.4万 | 12.60%6,828.1万 | 6.42%6,240.6万 | 42.72%2.39亿 | 27.87%5,689.4万 | 36.15%6,262.4万 | 38.18%6,064.1万 | 77.97%5,864万 | 49.22%1.67亿 | 77.16%4,449.4万 |
营业费用 | 5.29%4,678.6万 | 4.70%4,759.4万 | 0.58%4,388.3万 | 22.66%1.77亿 | 4.63%4,309.4万 | 27.91%4,443.5万 | 29.70%4,545.7万 | 32.18%4,362.9万 | 80.44%1.44亿 | 62.78%4,118.8万 |
销售和管理费用 | 5.29%4,678.6万 | 4.70%4,759.4万 | 0.58%4,388.3万 | 22.66%1.77亿 | 4.63%4,309.4万 | 27.91%4,443.5万 | 29.70%4,545.7万 | 32.18%4,362.9万 | 80.44%1.44亿 | 62.78%4,118.8万 |
-销售费用 | 10.37%1,645.7万 | 6.74%1,642.1万 | 8.21%1,545.4万 | 30.29%5,948.8万 | 14.88%1,491.1万 | 33.54%1,491.1万 | 33.82%1,538.4万 | 42.61%1,428.2万 | 126.26%4,565.7万 | 68.66%1,298万 |
-管理费用 | 2.73%3,032.9万 | 3.66%3,117.3万 | -3.13%2,842.9万 | 19.12%1.17亿 | -0.09%2,818.3万 | 25.24%2,952.4万 | 27.68%3,007.3万 | 27.64%2,934.7万 | 64.93%9,832.7万 | 60.21%2,820.8万 |
营业利润 | -31.51%1,245.8万 | 36.24%2,068.7万 | 23.40%1,852.3万 | 166.42%6,218.4万 | 317.42%1,380万 | 61.61%1,818.9万 | 71.80%1,518.4万 | 25,981.03%1,501.1万 | -27.83%2,334.1万 | 1,858.51%330.6万 |
净非营业利息收入(费用) | 100.73%550.4万 | 15.58%81.6万 | -23.11%63.2万 | 305.90%330.4万 | -589.46%-274.1万 | 1,257.43%274.2万 | 1,665.00%70.6万 | 6,750.00%82.2万 | 76.57%81.4万 | 574.70%56万 |
利息收入 | 100.73%550.4万 | 15.58%81.6万 | -23.11%63.2万 | ---- | ---- | 1,257.43%274.2万 | 1,665.00%70.6万 | 6,750.00%82.2万 | ---- | ---- |
其他财务费用 | ---- | ---- | ---- | -305.90%-330.4万 | ---- | ---- | ---- | ---- | -76.57%-81.4万 | ---- |
其他净收入(费用) | 179.09%356.4万 | 574.70%336万 | 1,719.23%520.3万 | 5,008.00%127.7万 | 618.75%49.8万 | 178.14%28.6万 | 193.86%27.5万 | |||
其他非经营收入(费用) | ---- | 179.09%356.4万 | 574.70%336万 | 1,719.23%520.3万 | ---- | ---- | 5,008.00%127.7万 | 618.75%49.8万 | 178.14%28.6万 | 193.86%27.5万 |
税前利润 | -14.18%1,796.2万 | 46.02%2,506.7万 | 37.87%2,251.5万 | 189.23%7,069.1万 | 292.71%1,626.2万 | 81.39%2,093.1万 | 92.82%1,716.7万 | 11,600.70%1,633.1万 | -24.65%2,444.1万 | 1,140.45%414.1万 |
所得税 | 49.83%754.1万 | 294.39%858.2万 | 517.00%561.7万 | 246.26%865.4万 | 280.90%279.2万 | 401.02%503.3万 | 1,511.85%217.6万 | 73.66%-134.7万 | 82.25%-591.7万 | 104.74%73.3万 |
除税后利润 | -34.45%1,042.1万 | 9.97%1,648.5万 | -4.41%1,689.8万 | 104.35%6,203.7万 | 295.25%1,347万 | 20.34%1,589.8万 | 70.97%1,499.1万 | 255.62%1,767.8万 | -53.84%3,035.8万 | -77.40%340.8万 |
持续经营利润 | -34.45%1,042.1万 | 9.97%1,648.5万 | -4.41%1,689.8万 | 104.35%6,203.7万 | 295.25%1,347万 | 20.34%1,589.8万 | 70.97%1,499.1万 | 255.62%1,767.8万 | -53.84%3,035.8万 | -77.40%340.8万 |
归属于少数股东的净利润 | ||||||||||
归属于母公司的净利润 | -34.45%1,042.1万 | 9.97%1,648.5万 | -4.41%1,689.8万 | 104.35%6,203.7万 | 295.25%1,347万 | 20.34%1,589.8万 | 70.97%1,499.1万 | 255.62%1,767.8万 | -53.84%3,035.8万 | -77.40%340.8万 |
优先股派息 | ||||||||||
其他优先股派息 | ||||||||||
归属于普通股股东的净利润 | -34.45%1,042.1万 | 9.97%1,648.5万 | -4.41%1,689.8万 | 104.35%6,203.7万 | 295.25%1,347万 | 20.34%1,589.8万 | 70.97%1,499.1万 | 255.62%1,767.8万 | -53.84%3,035.8万 | -77.40%340.8万 |
基本每股收益 | -29.41%0.12 | 12.50%0.18 | -5.26%0.18 | 96.97%0.65 | 250.00%0.14 | 21.43%0.17 | 60.00%0.16 | 280.00%0.19 | -55.41%0.33 | -76.47%0.04 |
稀释每股收益 | -31.25%0.11 | 13.33%0.17 | -5.56%0.17 | 106.67%0.62 | 333.33%0.13 | 23.08%0.16 | 66.67%0.15 | 260.00%0.18 | -54.55%0.3 | -80.00%0.03 |
每股派息 | ||||||||||
货币单位 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
会计准则 | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
审计意见 | -- | -- | -- | 无保留意见 | -- | -- | -- | -- | -- | -- |